Antitrust Antitrust

Teva, Cephalon fined EUR60.5 million in EU pay-for-delay probe

By Lewis Crofts
  • 26 Nov 2020 06:15
  • 26 Nov 2020 06:51
Pharmaceutical companies Teva and Cephalon must pay 60.5 million euros in fines ($72 million) after the European Commission concluded the companies agreed to delay the market entry of a cheaper drug to treat sleep disorders.

The probe focused on modafinil and sees the EU regulator again sanction conduct where pharmaceutical companies exchange

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News